Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115064) titled 'Evaluation of the analgesic effect of liposomal bupivacaine posterior spinal I nerve block for percutaneous vertebroplasty' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: No. 1 Orthopedics Hospital of Chengdu
Condition:
percutaneous vertebroplasty
Intervention:
High-concentration bupivacaine liposome group(HB Group):HB group: Ultrasound-guided bilateral thoracic/lumbar posterior nerve root block was performed. The medication used was 0.133% liposomal bupivacaine (Jiangsu Hengrui Pharmaceutical Co., Ltd., batch number: H20223899) at a dose of 20 mL: 266 mg
low-con...